"Angelique, I am so impressed with your research in TNBC from your compound discovery to cause cancer cells to burst and flatten, reversing multi-drug resistance in metastatic TNBC when added to existing drugs, no significant changes in toxicity in mice models and reducing size and weight of the tumor. This is huge for us survivors in the TNBC Community. As a 10 year survivor of Triple Negative Breast Cancer, the fear of recurrence is real, all of us survivors fear it. I have seen too many TNBC sisters pass after exhausting many clinical trials and a fierce battle.
I am excited in the direction your research is going, this gives us much hope that this may be our targeted therapy."
June 2019, Angelique has successfully defended her research defense in her doctoral thesis from Dr. Tiwari's lab on ‘Discovery of novel necroptosis inducers for triple negative breast cancer therapy’. Congrats Dr. Angelique on this incredible honor and receiving your PhD. - Melissa
 |
| Angelique's Defense |
 |
| Angelique and Melissa |